← Home / TREACE MEDICAL CONCEPTS, INC. (TMCI)
Stock Analysis

TREACE MEDICAL CONCEPTS, INC. (TMCI)

TMCI
TMCI · Healthcare • Medical Devices
4.72 -1.26%
Track TMCI in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when TMCI price is:
52W Range Position
56%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-26 21:19 UTC
WOI Investment Thesis
Constructive
Watch confirmation and structural levels before acting.
⚖️
✓
Fundamentals
Weak / Negative / Pressured / Manageable
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
No reliable structural support level is currently available.
Not available
↗
Break Above
No setup-specific trigger is available; nearest structural resistance is shown.
4.77
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
7
●
Financial Results
HIGH
TMCI reports financial results
On August 7, 2026, Treace Medical Concepts, Inc.
8-K Filing • SEC EDGAR
MAY
8
●
Financial Results
HIGH
Treace Medical Concepts Reports First Quarter 2026 Financial Results
("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the first quarter ended March 31, 2026.
8-K Filing • SEC EDGAR
What's Driving TMCI?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Revenue growth is weak. Profitability is negative. Cash generation is pressured. Balance-sheet quality is manageable.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
56.0
Price Chart
TMCI — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-25
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$284.2M
Company size
EV
$311.6M
Debt-adjusted value
P/S
1.4
Low sales multiple
P/B
4.2
Balanced
EV/Sales
1.5
Low sales multiple
EV/EBIT
-4.6
Not meaningful
P/FCF
-45.5
Not meaningful
FCF Yield
-2.20%
Cash return
Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Manageable
💵 Revenue
45.38M
↘ Weak
📈 Net Income
-15.87M
↘ Negative
🧮 EPS (Basic)
-0.24
↘ Negative
TREACE MEDICAL CONCEPTS, INC.
Healthcare • Medical Devices
You Might Also Like